| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Feld Michael | EVP, CRO & Pres. Life Sciences | C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES | Donna Kalazdy, by power of attorney from Michael Feld | 02 Dec 2025 | 0002034349 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BDX | Common Stock | Sale | $14,502 | -75 | -0.45% | $193.36 | 16,580 | 01 Dec 2025 | Direct |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 7, 2025.